Contraception
Volume 77, Issue 5 , Pages 371-376 , May 2008

Hormonal contraception and HIV prevalence in four African countries

  • Pauline M. Leclerc

      Affiliations

    • Institut Pasteur, Epidémiologie des Maladies Emergentes, and Université Paris VI, 75015 Paris, France
    • Corresponding Author InformationCorresponding author. Institut Pasteur, Epidémiologie des Maladies Emergentes, 25 rue du Docteur Roux, 75015 Paris, France. Tel.: +33 1 40 61 39 65; fax: +33 1 45 68 88 76.
    • ,
  • Nicolas Dubois-Colas

      Affiliations

    • Institut Pasteur, Epidémiologie des Maladies Emergentes, and Ecole Normale Supérieure, 94230 Cachan, France
    • ,
  • Michel Garenne

      Affiliations

    • Institut Pasteur, Epidémiologie des Maladies Emergentes, and Institut de Recherche pour le Développement, Paris, France

Received 6 October 2007 ,Revised 14 January 2008 ,Accepted 14 January 2008.

References 

  1. Wang CC, Reilly M, Kreiss JK. Risk of HIV infection in oral contraceptive pill users: a meta-analysis. J Acquir Immune Defic Syndr. 1999;21:51–58
  2. Mauck C. Overview of why hormones may be an issue. J Acquir Immune Defic Syndr. 2005;38(Suppl 1):S11–S12
  3. Martin HL, Richardson BA, Mandaliya K, Achola JO, Overbaugh J, Kreiss JK. The early work on hormonal contraceptive use and HIV acquisition. J Acquir Immune Defic Syndr. 2005;38(Suppl 1):S12–S14
  4. Morrison CS, Richardson BA, Celentano DD, et al. Prospective clinical trials designed to assess the use of hormonal contraceptives and risk of HIV acquisition. J Acquir Immune Defic Syndr. 2005;38(Suppl 1):S17–S18
  5. Baeten JM, Lavreys L, Overbaugh J. The influence of hormonal contraceptive use on HIV-1 transmission and disease progression. Clin Infect Dis. 2007;45:360–369
  6. Rehle T, Brinkmann UK, Siraprapasiri T, Coplan P, Aiemsukawat C, Ungchusak K. Risk factors of HIV-1 infection among female prostitutes in Khon Kaen, Northeast Thailand. Infection. 1992;20:328–331
  7. Plummer FA, Simonsen JN, Cameron DW, et al. Cofactors in male–female sexual transmission of human immunodeficiency virus type 1. J Infect Dis. 1991;163:233–239
  8. Martin HL, Nyange PM, Richardson BA, et al. Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. J Infect Dis. 1998;178:1053–1059
  9. Bulterys M, Chao A, Habimana P, Dushimimana A, Nawrocki P, Saah A. Incident HIV-1 infection in a cohort of young women in Butare, Rwanda. AIDS. 1994;8:1585–1591
  10. Sangi-Haghpeykar H, Posner SF, Poindexter AN. Consistency of condom use among low-income hormonal contraceptive users. Perspect Sex Reprod Health. 2005;37:184–191
  11. Miller CJ, Alexander NJ, Vogel P, Anderson J, Marx PA. Mechanism of genital transmission of SIV: a hypothesis based on transmission studies and the location of SIV in the genital tract of chronically infected female rhesus macaques. J Med Primatol. 1992;21:64–68
  12. Shattock RJ, Moore JP. Inhibiting sexual transmission of HIV-1 infection. Nat Rev Microbiol. 2003;1:25–34
  13. Lackner AA, Veazey RS. Current concepts in AIDS pathogenesis: insights from the SIV/macaque model. Annu Rev Med. 2007;58:461–476
  14. Hild-Petito S, Veazey RS, Larner JM, Reel JR, Blye RP. Effects of two progestin-only contraceptives, Depo-Provera and Norplant-II, on the vaginal epithelium of rhesus monkeys. AIDS Res Hum Retroviruses. 1998;14(Suppl 1):S125–S130
  15. Marx PA, Spira AI, Gettie A, et al. Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med. 1996;2:1084–1089
  16. Smith SM, Baskin GB, Marx PA. Estrogen protects against vaginal transmission of simian immunodeficiency virus. J Infect Dis. 2000;182:708–715
  17. Smith SM, Mefford M, Sodora D, et al. Topical estrogen protects against SIV vaginal transmission without evidence of systemic effect. AIDS. 2004;18:1637–1643
  18. Mauck CK, Callahan MM, Baker J, et al. The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy. Contraception. 1999;60:15–24
  19. Miller L, Patton DL, Meier A, Thwin SS, Hooton TM, Eschenbach DA. Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium. Obstet Gynecol. 2000;96:431–439
  20. Bahamondes L, Trevisan M, Andrade L, et al. The effect upon the human vaginal histology of the long-term use of the injectable contraceptive Depo-Provera. Contraception. 2000;62:23–27
  21. Poonia B, Walter L, Dufour J, Harrison R, Marx PA, Veazey RS. Cyclic changes in the vaginal epithelium of normal rhesus macaques. J Endocrinol. 2006;190:829–835
  22. Quinn TC, Overbaugh J. HIV/AIDS in women: an expanding epidemic. Science. 2005;308:1582–1583
  23. Central Statistical Office [Zambia] . Census 2001. Central Board of Health, and ORC Macro. Zambia Demographic and Health Survey 2001-2002. Calverton (Md): Central Statistical Office, Central Board of Health, and ORC; 2003;Available at http://www.measuredhs.com
  24. Ungchusak K, Rehle T, Thammapornpilap P, Spiegelman D, Brinkmann U, Siraprapasiri T. Determinants of HIV infection among female commercial sex workers in northeastern Thailand: results from a longitudinal study. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;12:500–507
  25. Kilmarx PH, Limpakarnjanarat K, Mastro TD, et al. HIV-1 seroconversion in a prospective study of female sex workers in northern Thailand: continued high incidence among brothel-based women. AIDS. 1998;12:1889–1898
  26. Kiddugavu M, Makumbi F, Wawer MJ, et al. Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda. AIDS. 2003;17:233–240
  27. Sinei SK, Fortney JA, Kigondu CS, et al. Contraceptive use and HIV infection in Kenyan family planning clinic attenders. Int J STD AIDS. 1996;7:65–70
  28. Kapiga SH, Lyamuya EF, Lwihula GK, Hunter DJ. The incidence of HIV infection among women using family planning methods in Dar es Salaam, Tanzania. AIDS. 1998;12:75–84
  29. Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS. 1993;7:95–102

PII: S0010-7824(08)00061-9

doi: 10.1016/j.contraception.2008.01.012

Contraception
Volume 77, Issue 5 , Pages 371-376 , May 2008

Article Tools